1. Yu M, Chang Y, Zhai Y, Pang B, Wang P, Li G*, Jiang T*, Zeng F*.TREM2 is associated with tumor immunity and implies poor prognosis in glioma.Front Immunol.2023.13.1089266.SCI |
2. Zeng F#, Li G#, Liu X, Zhang K, Huang H, Jiang T*, Zhang Y*.Plasminogen Activator Urokinase Receptor Implies Immunosuppressive Features and Acts as an Unfavorable Prognostic Biomarker in Glioma.Oncologist.2021.26(8).e1460-e1469.SCI |
3. Zhang Y, Liu Y, Liu H, Zhao Z, Wu F, Zeng F*.Clinical and Biological Significances of a Methyltransferase-Related Signature in Diffuse Glioma.Front Oncol.2020.10.508.SCI |
4. Zeng F#, Wang K#, Liu X, Zhao Z*.Comprehensive profiling identifies a novel signature with robust predictive value and reveals the potential drug resistance mechanism in glioma.Cell Commun Signal.2020.18(1).2.SCI |
5. Zeng F#*, Liu X#, Wang K, Zhao Z, Li G.Transcriptomic Profiling Identifies a DNA Repair-Related Signature as a Novel Prognostic Marker in Lower Grade Gliomas.Cancer Epidemiol Biomarkers Prev.2019.28(12).2079-2086.SCI |